In our study, IL4I1 was highly expressed in tumors and was notably more abundant in the cancer-immune zone of treatment-sensitive samples, consistent with its role in promoting tumor progression and suppressing anti-tumor immunity 38. Here, IL4I1 is linked to cancer.